Mayo Clinic Laboratories is committed to security and to protecting your information. As part of this commitment, we will implement an optional two-step login process for Mayo Clinic Laboratories applications called Multi-Factor Authentication (MFA). This process is like the two-step login process used by many other apps and provides an extra layer of security.

This fall, healthcare professionals and laboratory outreach enthusiasts will travel to Chicago to attend Mayo Clinic's annual conference, "Leveraging the Laboratory." Outreach manager Jane Hermansen along with outreach solution strategists, Ellen Dijkman Dulkes and Brianne Newton, are excited to extend a warm welcome to fellow colleagues and peers. This year's conference will be held in the Windy City for the first time, promising an exceptional experience for all participants.

Did you miss our 2023 live Phlebotomy Conference? Our two-day virtual conference remix, happening Oct. 12–13, will offer attendees the opportunity to view select recordings from this year’s live conference and get questions answered in real time by the presenters. Attendees will also learn techniques for staffing, engagement, and retention, to help empower employees.

Hurricane Hilary will be impacting the West Coast this weekend and into early next week. We are monitoring and tracking the situation with our logistics partners to minimize challenges. Clients will be contacted directly by the couriers if a route is modified or canceled due to the storm. Additionally, we are identifying and activating alternate solutions to help deliver client specimens to Mayo Clinic Laboratories. 

A team of researchers has confirmed that neutralizing monoclonal antibody (nMAb) therapies are associated with reduced risk of adverse outcomes of COVID-19 in high-risk populations. The cohort study, published in JAMA, included more than 167,000 nonhospitalized patients from health care systems based in California, Texas, and Utah, and at Mayo Clinic in Rochester, Minnesota.

Visit Mayo Clinic Laboratories at booth #2047 to learn about our comprehensive therapeutics test offerings. Developed by board-certified experts in clinical chemistry, molecular, and toxicology testing, our testing is designed to detect and monitor therapeutic and illicit drugs across several relevant specimen types.

Join us for the APA Annual Meeting 2023, the premier event for psychiatrists and mental health professionals. This year's meeting will be held May 20–24 in San Francisco and will feature an exciting program of educational sessions, expert speakers, and networking opportunities.

A medical mystery surrounding a clotting disease spurred a collaboration between Mayo Clinic and University of Michigan Health to develop a new test methodology and the discovery of a previously unknown blood clotting condition.

A specific type of fungal species, Candida auris, is raising concern in health care facilities around the world. First discovered in Japan in 2009, Candida auris is responsible for an increasing number of serious and often fatal fungal infections. Nancy Wengenack, Ph.D., director of the Mycology and Mycobacteriology Laboratories at Mayo Clinic Laboratories, explains why these infections are difficult to treat.

Thank you to all laboratory professionals for their efforts to provide critical answers for patients every day, and drive innovation in the field of medicine.

Top highlights include: Millions expected to lose dental care coverage, overdose deaths of elderly on the rise, and Minnesota Health Department urges caution for well owners as flood waters rise.

Matthew Binnicker, Ph.D., director of Mayo Clinic’s Clinical Virology Laboratory, provides insight on the newest COVID-19 subvariant – XBB.1.16, also known as “Arcturus.”